Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Corrigendum

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum]

       
Total article views   HTML views PDF downloads Totals
2,356 Dovepress* 2,280+ 315 2,595
PubMed Central* 76 41 117
Totals 2,356 356 2,712
*Since 14 July 2021

View citations on PubMed and Google Scholar